InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733
$4.78 +0.42% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.78 +27.13% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 25 Jul 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue66.9Operating income−0.1Net income−8.9Fiscal year 2018Revenue67.4 +0.8%Operating income−48.9Net income−61.4Fiscal year 2019Revenue52.6 −22.0%Operating income−52.7Net income−66.2Fiscal year 2020Revenue45.8 −12.8%Operating income−42.9Net income−55.8EPS, diluted−1.66Fiscal year 2021Revenue50.8 +10.9%Operating income−34.7Net income−70.5EPS, diluted−1.85Fiscal year 2022Revenue47.7 −6.2%Operating income−42.1Net income−54.4EPS, diluted−1.12Fiscal year 2023Revenue50.6 +6.1%Operating income−15.1Net income−7.9EPS, diluted−0.13Fiscal year 2024Revenue57.6 +13.8%Operating income−30.8Net income−44.1EPS, diluted−0.51Fiscal year 2025Revenue44.5 −22.6%Operating income−71.1Net income−83.8EPS, diluted−0.78
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 66.9 67.4 52.6 45.8 50.8 47.7 50.6 57.6 44.5
Growth +0.8% −22.0% −12.8% +10.9% −6.2% +6.1% +13.8% −22.6%
Operating income −0.1 −48.9 −52.7 −42.9 −34.7 −42.1 −15.1 −30.8 −71.1
Net income −8.9 −61.4 −66.2 −55.8 −70.5 −54.4 −7.9 −44.1 −83.8
Growth
EPS, diluted n/a n/a n/a −1.66 −1.85 −1.12 −0.13 −0.51 −0.78
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−0.2%Net margin−13.4%Free cash flow margin5.6%Fiscal year 2018Operating margin−72.6%Net margin−91.0%Free cash flow margin−22.0%Fiscal year 2019Operating margin−100.1%Net margin−125.9%Free cash flow margin−115.7%Fiscal year 2020Operating margin−93.6%Net margin−121.7%Free cash flow margin−100.3%Fiscal year 2021Operating margin−68.2%Net margin−138.8%Free cash flow margin−66.7%Fiscal year 2022Operating margin−88.2%Net margin−114.1%Free cash flow margin−22.7%Fiscal year 2023Operating margin−29.9%Net margin−15.6%Free cash flow margin−14.6%Fiscal year 2024Operating margin−53.5%Net margin−76.7%Free cash flow margin−62.4%Fiscal year 2025Operating margin−159.5%Net margin−188.1%Free cash flow margin−119.0%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −0.2% −72.6% −100.1% −93.6% −68.2% −88.2% −29.9% −53.5% −159.5%
Net margin −13.4% −91.0% −125.9% −121.7% −138.8% −114.1% −15.6% −76.7% −188.1%
Free cash flow margin 5.6% −22.0% −115.7% −100.3% −66.7% −22.7% −14.6% −62.4% −119.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow5.8Capital expenditure−2.1Free cash flow3.8Fiscal year 2018Operating cash flow−13.0Capital expenditure−1.8Free cash flow−14.8 −494.4%Fiscal year 2019Operating cash flow−60.2Capital expenditure−0.7Free cash flow−60.9Fiscal year 2020Operating cash flow−45.5Capital expenditure−0.5Free cash flow−46.0Fiscal year 2021Operating cash flow−33.0Capital expenditure−0.9Free cash flow−33.9Fiscal year 2022Operating cash flow−9.8Capital expenditure−1.0Free cash flow−10.8Fiscal year 2023Operating cash flow−6.4Capital expenditure−1.0Free cash flow−7.4Fiscal year 2024Operating cash flow−35.8Capital expenditure−0.2Free cash flow−35.9Fiscal year 2025Operating cash flow−52.4Capital expenditure−0.6Free cash flow−53.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 5.8 −13.0 −60.2 −45.5 −33.0 −9.8 −6.4 −35.8 −52.4
Capital expenditure −2.1 −1.8 −0.7 −0.5 −0.9 −1.0 −1.0 −0.2 −0.6
Free cash flow 3.8 −14.8 −60.9 −46.0 −33.9 −10.8 −7.4 −35.9 −53.0
Growth −494.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash17.4Shareholders’ equity−26.5Fiscal year 2018Cash60.6Shareholders’ equity10.1Fiscal year 2019Cash49.3Total debt70.0Net cash (debt)−20.7Shareholders’ equity−6.1Fiscal year 2020Cash31.8Total debt51.5Net cash (debt)−19.7Shareholders’ equity−48.5Fiscal year 2021Cash28.0Shareholders’ equity−82.1Fiscal year 2022Cash27.3Shareholders’ equity−118.6Fiscal year 2023Cash23.9Total debt45.0Net cash (debt)−21.1Shareholders’ equity−106.5Fiscal year 2024Cash71.5Total debt45.0Net cash (debt)26.5Shareholders’ equity−60.2Fiscal year 2025Cash121.2Total debt45.0Net cash (debt)76.2Shareholders’ equity−33.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.4 60.6 49.3 31.8 28.0 27.3 23.9 71.5 121.2
Total debt n/a n/a 70.0 51.5 n/a n/a 45.0 45.0 45.0
Net cash (debt) n/a n/a −20.7 −19.7 n/a n/a −21.1 26.5 76.2
Shareholders’ equity −26.5 10.1 −6.1 −48.5 −82.1 −118.6 −106.5 −60.2 −33.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
5.8 −13.0 −60.2 −45.5 −33.0 −9.8 −6.4 −35.8 −52.4
Growth −323.1%
3.8 3.2 n/a n/a n/a n/a n/a n/a n/a
Investment
−2.1 −1.8 −0.7 −0.5 −0.9 −1.0 −1.0 −0.2 −0.6
calc 3.8 −14.8 −60.9 −46.0 −33.9 −10.8 −7.4 −35.9 −53.0
Growth −494.4%
calc n/a n/a n/a −1.37 −0.89 −0.22 −0.12 −0.41 −0.50
−2.1 −1.8 −0.7 −0.5 −0.9 −2.5 −1.0 −0.2 −0.6
Financing
4.4 58.0 49.6 28.5 30.1 11.6 4.0 83.6 102.6

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.